| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2862898 | American Journal of Hypertension | 2006 | 6 Pages |
Abstract
Add-on spironolactone is a highly effective add-on treatment in UH, mainly in patients with low serum potassium levels. Further studies assessing serum potassium as a marker for treatment approach are needed to establish the role of aldosterone antagonists in the management of UH.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Yehonatan Sharabi, Eldad Adler, Ari Shamis, Naomi Nussinovitch, Avinoam Markovitz, Ehud Grossman,